PHK
Point72 Hong Kong’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Buy |
53,946
+26,154
| +94% | +$564K | 0.08% | 185 |
|
|
2025
Q1 | $462K | Buy |
27,792
+3,738
| +16% | +$62.1K | 0.03% | 246 |
|
|
2024
Q4 | $441K | Buy |
+24,054
| New | +$441K | 0.03% | 242 |
|
|
2024
Q3 | – | Sell |
-28,054
| Closed | -$456K | – | 431 |
|
|
2024
Q2 | $456K | Hold |
28,054
| – | – | 0.03% | 245 |
|
|
2024
Q1 | $519K | Buy |
28,054
+16,673
| +146% | +$308K | 0.03% | 332 |
|
|
2023
Q4 | $356K | Buy |
+11,381
| New | +$356K | 0.02% | 383 |
|
|
2022
Q3 | – | Sell |
-22,813
| Closed | -$321K | – | 1350 |
|
|
2022
Q2 | $321K | Buy |
22,813
+16,810
| +280% | +$237K | 0.01% | 479 |
|
|
2022
Q1 | $145K | Buy |
6,003
+5,218
| +665% | +$126K | 0.01% | 567 |
|
|
2021
Q4 | $18K | Sell |
785
-6,962
| -90% | -$160K | ﹤0.01% | 1006 |
|
|
2021
Q3 | $129K | Sell |
7,747
-1,741
| -18% | -$29K | ﹤0.01% | 674 |
|
|
2021
Q2 | $231K | Buy |
9,488
+1,455
| +18% | +$35.4K | 0.01% | 569 |
|
|
2021
Q1 | $207K | Buy |
+8,033
| New | +$207K | 0.01% | 536 |
|
|
2020
Q3 | – | Sell |
-13,026
| Closed | -$631K | – | 1147 |
|
|
2020
Q2 | $631K | Buy |
+13,026
| New | +$631K | 0.07% | 286 |
|
|
2020
Q1 | – | Sell |
-295
| Closed | -$13K | – | 904 |
|
|
2019
Q4 | $13K | Buy |
+295
| New | +$13K | ﹤0.01% | 944 |
|
|
2018
Q3 | – | Sell |
-3,591
| Closed | -$55K | – | 848 |
|
|
2018
Q2 | $55K | Sell |
3,591
-848
| -19% | -$13K | 0.02% | 406 |
|
|
2018
Q1 | $100K | Buy |
4,439
+3,958
| +823% | +$89.2K | 0.05% | 322 |
|
|
2017
Q4 | $14K | Buy |
481
+431
| +862% | +$12.5K | 0.01% | 433 |
|
|
2017
Q3 | $2K | Buy |
+50
| New | +$2K | ﹤0.01% | 637 |
|
|
2017
Q2 | – | Sell |
-619
| Closed | -$21K | – | 781 |
|
|
2017
Q1 | $21K | Sell |
619
-604
| -49% | -$20.5K | 0.03% | 394 |
|
|
2016
Q4 | $35K | Buy |
+1,223
| New | +$35K | 0.03% | 441 |
|